-
  
genzyme corporationresearchgenzyme websites
Health Care Provider InfoSYNVISC Providor LocatorContact Us
HomeAbout OsteoarthritisAbout SYNVISCKnee Pain Resources
search
SYNVISC - HYLAN G-F 20
increase text sizedecrease text size
Are you a Healthcare Professional?

Visit our website for U.S. healthcare professionals.

go

Not in the U.S?

Looking for a SYNVISC Provider Near You?
Search by your ZIP code & distance to get a list of SYNVISC providers in your area.
ZIP Code:
Distance: Go
Want a FREE Knee Pain Relief Packet?

Receive a FREE DVD and booklet about SYNVISC.

go

Discover Osteoarthritis
Knee Pain Relief

Living with osteoarthritis (OA) knee pain can be challenging—but it doesn’t have to be painful. Find out how SYNVISC®, an FDA-approved therapy, may be able to provide you with up to 6 months of pain relief.

How Does SYNVISC Work?

Is SYNVISC Right For Me?

How Is SYNVISC Different From Other Treatments?

Is SYNVISC ccovered By Insurance?

Important Safety Information

SYNVISC is used to relieve knee pain due to osteoarthritis (OA). It is for patients who do not get enough relief from simple painkillers such as acetaminophen, or from exercise and physical therapy.

SYNVISC is generally well tolerated. However, it may not work for everyone. The side effects most commonly seen when SYNVISC is injected into the knee were pain, swelling and/or fluid buildup around the knee. Cases where the swelling is extensive or painful should be discussed with your doctor. Other side effects such as rash have been reported rarely. Before trying SYNVISC, tell your doctor if you are allergic to products from birds—such as feathers, eggs or poultry—or if your leg is swollen or infected. Talk to your doctor before resuming strenuous weight-bearing activities after treatment. SYNVISC has not been tested in children, pregnant women or women who are nursing. You should tell your doctor if you think you are pregnant or if you are nursing a child.

View the Important Patient Information and Complete Prescribing Information for SYNVISC (PDF, 146k)